Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

Diabetes Technology&Therapeutics,Volume 21, Issue 9, Page 471-477, September 2019.

Source: Diabetes Technology - August 18, 2019 Category: Endocrinology Authors: Thomas Danne Jeremy Pettus Andrea Giaccari Bertrand Cariou Helena Rodbard Stuart A. Weinzimer Mireille Bonnemaire Sangeeta Sawhney John Stewart Stella Wang Rita de Cassia Castro Satish K. Garg Source Type: research